Lung Cancer Clinical Trials
Lung Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for lung Cancer. Corterve aggregates actively recruiting Lung Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Lung Cancer studies
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Goodyear, Arizona
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701PHASE1PfizerFayetteville, Arkansas
- Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCNCT07489066PHASE2PfizerHuntsville, Alabama
- Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844PHASE3National Cancer Institute (NCI)Fayetteville, Arkansas
- Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerNCT06287775PHASE1, PHASE2National Cancer Institute (NCI)Duarte, California
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsNCT02682667National Cancer Institute (NCI)Bethesda, Maryland
- A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsNCT06427941PHASE1BeOne MedicinesGoodyear, Arizona
- DK222 Study at HopkinsNCT07140315PHASE1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore, Maryland
- A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)NCT07227597PHASE1, PHASE2Merck Sharp & Dohme LLCSanta Rosa, California
- Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerNCT04181060PHASE3National Cancer Institute (NCI)Anchorage, Alaska
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingNCT06066138PHASE1National Cancer Institute (NCI)Bethesda, Maryland
- A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsNCT06792552PHASE1NextCure, Inc.Orlando, Florida
Lung Cancer trials by state
Lung Cancer trials by metro
Frequently asked questions
- How do I find recruiting Lung Cancer clinical trials?
- Corterve aggregates actively recruiting Lung Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Lung Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Lung Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.